ToxBank

Details

EwC Role: 
Project Partner
Duration: 
1 January 2011 - 31 December 2015
Client: 
FP7-HEALTH

ABOUT THIS PROJECT

ToxBank establishes a dedicated web-based warehouse for toxicity data management and modelling, a ‘gold standards’ compound database and repository of selected test compounds, and a reference resource for cells, cell lines and tissues of relevance for in vitro systemic toxicity research carried out across the FP7 HEALTH.2010.4.2.9 Alternative Testing Strategies SEURAT program.

The project develops infrastructure and service functions to create a sustainable predictive toxicology support resource going beyond the lifetime of the program.

The following activities were carried out:

  1. Establishment of a dedicated web-based data warehouse The ToxBank Data Warehouse will establish a centralised compilation of data for systemic toxicity. Data generated under the research program and additional public data will be uploaded and integrated whenever possible into computerised models capable of predicting repeated-dose toxicity.
  2. Establishment of a database of test compounds The ToxBank Gold Compound Database will provide a high quality information resource servicing the selection and use of test compounds. Chemicals in this database will be supported by high-quality repeated-dose toxicity in vivo and in vitro data, property data and, whenever available, human adverse event and epidemiological data. Selected test compounds for training or validation, and standard operating procedures for data quality control, processing and analyses will be provided.
  3. Establishment of a repository for the selected test compounds The ToxBank Chemical Repository will ensure the availability of test compounds to program researchers accompanied by sample preparation, handling and analytical quality control procedures.
  4. Setting up of a cell and tissue banking information resource for in vitro toxicity testing ToxBank will establish a banking information resource for access to qualified cells, cell lines (including stem cells and stem cell lines) and tissues and reference materials to be used for in vitro predictive toxicology research and testing activities.

Latest Tweets

Edelweiss Connect (1 week ago)
See the recording from our recent SaferWorldbyDesign Webinar and discussion: Skin safety assessment according to OE… https://t.co/woogWUa3aC
Edelweiss Connect (2 months ago)
#SaferWorldbyDesign presents: Skin safety assessment according to OECD guidelines Join us on December 14 for a we… https://t.co/6wnrD6P411
Edelweiss Connect (2 months ago)
JRC Data Visualization: Extrapolating from acute to chronic toxicity in vitro An important question that was addre… https://t.co/B5Ius3qtDk
Edelweiss Connect (2 months ago)
#SaferWorldbyDesign webinar: In Silico solutions for drug discovery Presented by @Maieutix1 #insilico… https://t.co/Ya5J0ySQ0Q
Edelweiss Connect (3 months ago)
See why @wepredic @Biopredic_Intl #HepaRG™ cell model is the best for NAFLD investigations #SaferWorldbyDesign… https://t.co/pzgJbUhY7d

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA